Tuesday, April 10, 2018 11:12:21 AM
Wow. And why wouldn't a company showing 10-15x its extraction technique in human trials not want to pursue the higher margin cannabis market? They would.. They will.. and are doing it the right way. These things take time.
Thank the market for giving you these stupid low prices and buy IMO. They won't be here much longer.
I've done the research. I come from a crypto background... This is where you want to be in terms of legal risks / reward. CBD is legal and transferable in all 50 states as it has no THC! I own like .27% of the current float though so take my word for what it's worth. I'm obviously long and stand to benefit from positive price action. But if these guys can execute.. I see no reason to move out of this name until it reaches "B"s for a valuation.
A premium CBD lifestyle brand / product in this market will reach premium valuations. The ability to scale at a fast pace is key to price appreciation in short order. You can check the boxes on all these fronts. A huge PPS increase is coming IMO. Be patient!
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM